Literature DB >> 23027871

Tollip, an intracellular trafficking protein, is a novel modulator of the transforming growth factor-β signaling pathway.

Lu Zhu1, Lingdi Wang, Xiaolin Luo, Yongxian Zhang, Qiurong Ding, Xiaomeng Jiang, Xiao Wang, Yi Pan, Yan Chen.   

Abstract

Upon activation, TGF-β type I receptor (TβRI) undergoes active ubiquitination via recruitment of E3 ligases to the receptor complex by Smad7. However, how ubiquitination of TβRI is coupled to intracellular trafficking, and protein degradation remains unclear. We report here that Tollip, an adaptor protein that contains both ubiquitin-associated domains and endosome-targeting domain, plays an important role in modulating trafficking and degradation of TβRI. Tollip was previously demonstrated to possess a functional role in modulating the signaling of interleukin-1 and Toll-like receptors. We identify here that Tollip interacts with Smad7, a major modulatory protein involved in the negative regulation of TGF-β signaling. Overexpression of Tollip antagonizes TGF-β-stimulated transcriptional response, Smad2 phosphorylation, and epithelial-mesenchymal transition. Tollip also interacts with ubiquitinated TβRI, and such interaction requires ubiquitin-associated domains of Tollip. The interaction and intracellular colocalization of Tollip with TβRI is enhanced by Smad7. Overexpression of Tollip accelerates protein degradation of activated TβRI. In addition, Tollip alters subcellular compartmentalization and endosomal trafficking of activated TβRI. Collectively, our studies reveal that Tollip cooperates with Smad7 to modulate intracellular trafficking and degradation of ubiquitinated TβRI, whereby negatively regulates TGF-β signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23027871      PMCID: PMC3501082          DOI: 10.1074/jbc.M112.388009

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor.

Authors:  K Burns; J Clatworthy; L Martin; F Martinon; C Plumpton; B Maschera; A Lewis; K Ray; J Tschopp; F Volpe
Journal:  Nat Cell Biol       Date:  2000-06       Impact factor: 28.824

2.  Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I.

Authors:  D J Katzmann; M Babst; S D Emr
Journal:  Cell       Date:  2001-07-27       Impact factor: 41.582

3.  Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.

Authors:  P Kavsak; R K Rasmussen; C G Causing; S Bonni; H Zhu; G H Thomsen; J L Wrana
Journal:  Mol Cell       Date:  2000-12       Impact factor: 17.970

4.  Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.

Authors:  T Ebisawa; M Fukuchi; G Murakami; T Chiba; K Tanaka; T Imamura; K Miyazono
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

5.  Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro.

Authors:  J M Fan; X R Huang; Y Y Ng; D J Nikolic-Paterson; W Mu; R C Atkins; H Y Lan
Journal:  Am J Kidney Dis       Date:  2001-04       Impact factor: 8.860

6.  Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling.

Authors:  Y Bulut; E Faure; L Thomas; O Equils; M Arditi
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

Review 7.  The Smad pathway.

Authors:  J L Wrana; L Attisano
Journal:  Cytokine Growth Factor Rev       Date:  2000 Mar-Jun       Impact factor: 7.638

8.  Negative regulation of toll-like receptor-mediated signaling by Tollip.

Authors:  Guolong Zhang; Sankar Ghosh
Journal:  J Biol Chem       Date:  2001-12-18       Impact factor: 5.157

9.  Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.

Authors:  Xiao-Feng Qin; Dong Sung An; Irvin S Y Chen; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

Review 10.  TGF-beta signal transduction.

Authors:  J Massagué
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

View more
  34 in total

1.  Toll interacting protein protects bronchial epithelial cells from bleomycin-induced apoptosis.

Authors:  Xiaoyun Li; Sharon E Kim; Ting-Yun Chen; Juan Wang; Xia Yang; Tracy Tabib; Jiangning Tan; Brandon Guo; Sonia Fung; Jing Zhao; John Sembrat; Mauricio Rojas; Sruti Shiva; Robert Lafyatis; Claudette St Croix; Jonathan K Alder; Y Peter Di; Daniel J Kass; Yingze Zhang
Journal:  FASEB J       Date:  2020-06-28       Impact factor: 5.191

Review 2.  Ubiquitin-dependent sorting in endocytosis.

Authors:  Robert C Piper; Ivan Dikic; Gergely L Lukacs
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-01-01       Impact factor: 10.005

3.  Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.

Authors:  Ana L Mora; Mauricio Rojas; Annie Pardo; Moises Selman
Journal:  Nat Rev Drug Discov       Date:  2017-10-30       Impact factor: 84.694

4.  Tollip-induced down-regulation of MARCH1.

Authors:  Marie-Claude Bourgeois-Daigneault; Abdul Mohammad Pezeshki; Tristan Galbas; Mathieu Houde; Martin Baril; Klaus Früh; Abdelaziz Amrani; Satoshi Ishido; Daniel Lamarre; Jacques Thibodeau
Journal:  Results Immunol       Date:  2013-02-20

Review 5.  Molecular biomarkers in idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Kevin K Brown; Harold R Collard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-26       Impact factor: 5.464

6.  Ubiquitin interacts with the Tollip C2 and CUE domains and inhibits binding of Tollip to phosphoinositides.

Authors:  Sharmistha Mitra; C Alicia Traughber; Mary K Brannon; Stephanie Gomez; Daniel G S Capelluto
Journal:  J Biol Chem       Date:  2013-07-23       Impact factor: 5.157

7.  Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.

Authors:  Yi Liu; Xiao-Li Jiang; Yu Liu; Ding-Sheng Jiang; Yan Zhang; Rui Zhang; Yingjie Chen; Qinglin Yang; Xiao-Dong Zhang; Guo-Chang Fan; Hongliang Li
Journal:  Cardiovasc Res       Date:  2013-11-26       Impact factor: 10.787

8.  Toll-Interacting Protein, Tollip, Inhibits IL-13-Mediated Pulmonary Eosinophilic Inflammation in Mice.

Authors:  Yoko Ito; Niccolette Schaefer; Amelia Sanchez; David Francisco; Rafeul Alam; Richard J Martin; Julie G Ledford; Connor Stevenson; Di Jiang; Liwu Li; Monica Kraft; Hong Wei Chu
Journal:  J Innate Immun       Date:  2018-01-27       Impact factor: 7.349

Review 9.  TGF-β Signaling from Receptors to Smads.

Authors:  Akiko Hata; Ye-Guang Chen
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

10.  Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.

Authors:  Imre Noth; Yingze Zhang; Shwu-Fan Ma; Dan Nicolae; Naftali Kaminski; Joe G N Garcia; Carlos Flores; Mathew Barber; Yong Huang; Steven M Broderick; Michael S Wade; Pirro Hysi; Joseph Scuirba; Thomas J Richards; Brenda M Juan-Guardela; Rekha Vij; MeiLan K Han; Fernando J Martinez; Karl Kossen; Scott D Seiwert; Jason D Christie
Journal:  Lancet Respir Med       Date:  2013-04-17       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.